“Covid-19 Vaccine” Adverse Reactions; Part Five: AstraZeneca product verges on being officially harmful, but why now?

This is a temporary article to keep the FBEL readership up to date with the tables that have been being created to track the percentage of “vaccine” doses that are associated with a MHRA Yellow card report and an adverse reaction. As can be seen in the pertinent table, there was a considerable drive to dispense the AstraZeneca product in the week between the 21st and 28th March, and the fall in the percentages for this product is what one would have expected to see from the outset of this tracking, if the “vaccine” was unrelated to harm, and as more of it was administered – this is point that the author has been belabouring in this series. That being said, the damage, so to speak, has already been done, as the AstraZeneca product climbed to quite the high watermark through 15 million previous doses.

And yet, given the MHRA and UK Government’s assertions that all “Covid-19 vaccines” are safe, it’s a huge surprise to see, on the back of a link to blood clotting,  that the AstraZeneca product is being withheld from the under-30s, and that trials for children (for Christ’s sake) involving the product are being suspended – and it is hoped that when this article is updated (which is the intention), then there will be an attempt to understand why a Millennial is so different to any other age demographic that it needs to be protected from the AstraZeneca product, or whether this is a politically motivated development. Moreover, there will be a closer look at the blood clot issue, and there will be an attempt to understand why the MHRA, which is the body that looks at these things, has decided that there might be a cause and effect relationship between the AstraZeneca product and this adverse reaction out of all the other adverse reactions that have been reported, sometimes with more frequency.

The author suspects that, whatever the MHRA really thinks, the blood clot situation might be being used as a pretext for that suspected political withdrawal of the product hinted at above. What we might be seeing in the huge rush to dispense the product up to the 28th March is the manifestation of a scorched earth policy ahead of the public losing confidence; for, it cannot be denied that the proclamations coming from UK Government about the AstraZeneca product are a huge public relations disaster. It remains to be seen how many volunteer for the second dose.

Millennials will still not be safe, of course, for another vaccine product – again, which they don’t need (and this cannot be stressed enough) – either the Pfizer one, or the new to the British scene Moderna product, will be offered to them. This means that the under-30s will only be able to receive the Frankenstein technology, because both products are mRNA-based “vaccines” – and it’s is very interesting that this scenario has apparently, oh so organically, emerged.

Previously in this series:

“Covid-19 Vaccine” Adverse Reactions; Part Four: A Tendency To Be More Injurious Than Expected (link).